Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG platform
Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG…
Lucid Diligence Brief: Clairity's $43 million Series B for Clairity Breast
Lucid Diligence Brief: Clairity's $43 million Series B for Clairity Breast…
Lucid Diligence Brief: Chiesi partners with Aliada (AbbVie) on BBB platform for LSDs
Lucid Diligence Brief: Chiesi partners with Aliada on BBB platform for LSDs…
Lucid Diligence Brief: INBRAIN and Microsoft partner on agentic AI for precision neurology and BCI
Lucid Diligence Brief: INBRAIN and Microsoft partner on agentic AI for…
Lucid Diligence Brief: Galecto acquires Damora Therapeutics
Lucid Diligence Brief: Galecto acquires Damora Therapeutics Professional…
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery Professional…
Lucid Diligence Brief: SanegeneBio and Lilly RNAi collaboration in metabolic diseases
Lucid Diligence Brief: SanegeneBio and Lilly RNAi collaboration in metabolic…
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding Professional audiences…
Lucid Diligence Brief: Lumonus A$25M Series B
Lucid Diligence Brief: Lumonus A$25M Series B Professional audiences only. Not…
Lucid Diligence Brief: Amae Health $25M Series B
Lucid Diligence Brief: Amae Health $25M Series B Professional audiences only.…
Lucid Diligence Brief: Braveheart Bio launches with $185M Series A
Lucid Diligence Brief: Braveheart Bio launches with $185M Series A Professional…
Lucid Diligence Brief: Azalea Therapeutics launches with $82M financing
Lucid Diligence Brief: Azalea Therapeutics launches with $82M financing…